SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-2.88%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$242M
AUM Growth
+$242M
(+3.8%)
Cap. Flow
+$16.7M
Cap. Flow
% of AUM
6.9%
Top 10 Holdings %
Top 10 Hldgs %
34.33%
Holding
60
New
15
Increased
15
Reduced
14
Closed
11
Top Buys
| 1 |
Centene
CNC
|
$5.89M |
| 2 |
Novo Nordisk
NVO
|
$5M |
| 3 |
Cigna
CI
|
$4.79M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$4.49M |
| 5 |
Medtronic
MDT
|
$3.88M |
Top Sells
| 1 |
Pfizer
PFE
|
$5.91M |
| 2 |
Eli Lilly
LLY
|
$5.01M |
| 3 |
Becton Dickinson
BDX
|
$4.4M |
| 4 |
Bristol-Myers Squibb
BMY
|
$4.37M |
| 5 |
Molina Healthcare
MOH
|
$3.98M |
Sector Composition
| 1 | Healthcare | 93.04% |
| 2 | Energy | 1.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P Biotech ETF
XBI
$5.07B
| $13.5M | 5.57% |
150,000
+50,000
| +50% | +$4.49M |
|
2
Boston Scientific
BSX
$156B
| $8.86M | 3.66% |
200,000
+40,000
| +25% | +$1.77M |
|
3
UnitedHealth
UNH
$281B
| $8.67M | 3.58% |
17,000
-500
| -3% | -$255K |
|
4
Danaher
DHR
$147B
| $8.07M | 3.33% |
27,500
+2,500
| +10% | +$733K |
|
5
Humana
HUM
$36.5B
| $7.83M | 3.23% |
18,000
+500
| +3% | +$218K |
|
6
Tenet Healthcare
THC
$16.3B
| $7.74M | 3.19% |
90,000
| – | – |
|
7
Thermo Fisher Scientific
TMO
$186B
| $7.38M | 3.05% |
12,500
| – | – |
|
8
Elevance Health
ELV
$71.8B
| $7.37M | 3.04% |
15,000
-2,500
| -14% | -$1.23M |
|
9
McKesson
MCK
$85.4B
| $6.89M | 2.84% |
22,500
-12,500
| -36% | -$3.83M |
|
10
Universal Health Services
UHS
$11.6B
| $6.89M | 2.84% |
47,500
-12,500
| -21% | -$1.81M |
|
11
Intuitive Surgical
ISRG
$170B
| $6.79M | 2.8% |
22,500
+12,301
| +121% | +$3.71M |
|
12
Johnson & Johnson
JNJ
$427B
| $6.2M | 2.56% |
35,000
+5,000
| +17% | +$886K |
|
13
Cencora
COR
$56.5B
| $6.19M | 2.55% |
40,000
-12,500
| -24% | -$1.93M |
|
14
Avantor
AVTR
$9.18B
| $6.09M | 2.51% |
180,000
| – | – |
|
15
CVS Health
CVS
$92.8B
| $6.07M | 2.51% |
60,000
+10,000
| +20% | +$1.01M |
|
|
16
Centene
CNC
$14.3B
| $5.89M | 2.43% |
+70,000
| New | +$5.89M |
|
17
Encompass Health
EHC
$12.3B
| $5.86M | 2.42% |
82,392
+52,392
| +175% | +$3.73M |
|
18
Charles River Laboratories
CRL
$8.04B
| $5.68M | 2.34% |
20,000
+5,000
| +33% | +$1.42M |
|
19
HCA Healthcare
HCA
$94.5B
| $5.64M | 2.33% |
22,500
-4,487
| -17% | -$1.12M |
|
20
Stryker
SYK
$150B
| $5.35M | 2.21% |
20,000
+7,500
| +60% | +$2.01M |
|
21
Abbott
ABT
$231B
| $5.33M | 2.2% |
45,000
-5,000
| -10% | -$592K |
|
22
Labcorp
LH
$23.1B
| $5.27M | 2.18% |
20,000
-2,500
| -11% | -$659K |
|
23
Zimmer Biomet
ZBH
$21B
| $5.12M | 2.11% |
40,000
-2,500
| -6% | -$320K |
|
|
24
Novo Nordisk
NVO
$251B
| $5M | 2.06% |
+45,000
| New | +$5M |
|
25
Globus Medical
GMED
$8.27B
| $4.8M | 1.98% |
65,000
-10,000
| -13% | -$738K |
|